Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Colorectal Dis ; 16(8): O273-82, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24456168

RESUMO

AIM: The diagnostic accuracy of the faecal immunochemical test (FIT) at a 100 ng/ml threshold for colorectal cancer (CRC) was compared with National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) referral criteria. METHOD: A multicentre, prospective, blind study of diagnostic tests was carried out in two Spanish health areas. In 787 symptomatic patients referred for a diagnostic colonoscopy, we determined whether patients met NICE and SIGN referral criteria. All patients performed one FIT determination (OCsensor(™) ). The sensitivity and specificity for CRC detection were determined with McNemar's test. The diagnostic odds ratio as well as the number needed to scope (NNS) to detect a CRC were calculated. RESULTS: We detected CRC in 97 (12.3%) patients; 241 (30.6%) had an FIT ≥ 100 ng/ml and 300 (38.1%) and 473 (60.1%) met NICE and SIGN referral criteria. The FIT had a higher sensitivity for CRC detection than NICE criteria (87.6%, 61.9%; P < 0.001) and SIGN criteria (82.5%; P = 0.4). The specificity of FIT was also higher than NICE and SIGN criteria (77.4%, 65.2%, 42.7%; P < 0.001). The odds ratios of FIT, NICE and SIGN criteria for the diagnosis of CRC were 24.24 (95% CI 12.91-45.53), 3.04 (95% CI 1.96-4.71) and 3.51 (95% CI 2.03-6.06). The NNS to detect a CRC in individuals with an FIT ≥ 100 ng/ml was 2.83 (95% CI 2.4-3.41) and in individuals who met NICE and SIGN criteria it was 5 (95% CI 3.98-6.37) and 5.95 (95% CI 4.85-7.35). CONCLUSION: Our study suggests that FIT is more accurate for the detection of CRC than the current NICE and SIGN referral criteria in symptomatic patients referred for colonoscopy.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias Colorretais/diagnóstico , Testes Diagnósticos de Rotina/métodos , Fezes/química , Adulto , Idoso , Idoso de 80 Anos ou mais , Colonoscopia , Detecção Precoce de Câncer , Feminino , Humanos , Imunoquímica , Masculino , Pessoa de Meia-Idade , Razão de Chances , Valor Preditivo dos Testes , Estudos Prospectivos , Encaminhamento e Consulta , Sensibilidade e Especificidade , Método Simples-Cego , Espanha
2.
Int Urol Nephrol ; 47(8): 1403-8, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26152646

RESUMO

It is known that the common physiological denominator of the ageing process is an attenuation of functional performance with respect to the situation of young people and adults. However, since the first cohort-based longitudinal studies, it has not been possible to establish a "linear" relationship between age and glomerular filtration in all cases. This does not mean that there is no physiological ageing process at all; in addition to those already elucidated, its mechanisms include cell senescence, podocyte dysfunction, a vitamin D deficiency, and homozygotic forms of the MYH9 gene. The aim of the present work was to analyse the prevalence of chronic kidney disease (CKD) and, where possible, the correlation between CKD, defined by an eGFR < 60 ml/min/1.73 m(2), plasma 25(OH)D3 levels and the MYH9 gene in a population of elderly and very elderly persons. These parameters have not been evaluated previously in populations of elderly and very elderly patients. It is concluded that a moderate decrease in the eGFR occurs with age. This does not imply the presence of CKD in elderly people, since in most individuals the reduced eGFR is not accompanied by anaemia, and no individuals show hypocalcaemia, hyperphosphataemia or a high Alb/Cr ratio. Here we observed a lower Hb level and an elevated Alb/Cr ratio in subjects heterozygotic for the MYH9 gene. This could be interpreted in the sense that the gene could exert some protective effect on renal function, whereas the heterozygotic form (allele A) of the MYH9 gene could be considered a very early marker, a new risk factor for the appearance of CKD, or a sign of renal frailty in elderly people.


Assuntos
Envelhecimento , Calcifediol/sangue , DNA/genética , Taxa de Filtração Glomerular/fisiologia , Proteínas Motores Moleculares/genética , Cadeias Pesadas de Miosina/genética , Polimorfismo Genético , Insuficiência Renal Crônica/genética , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas Motores Moleculares/metabolismo , Cadeias Pesadas de Miosina/metabolismo , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/fisiopatologia , Fatores de Risco , Adulto Jovem
3.
Rev Stomatol Chir Maxillofac ; 86(3): 156-64, 1985.
Artigo em Francês | MEDLINE | ID: mdl-3862223

RESUMO

The study and presentation of a typical case of discoid lupus erythematosus with oral lesions in a 30-years old woman, without visceral manifestations at present, was the motive for a revision and updating of the concepts of etiology, differential diagnosis, treatment and prognosis of this disease. The authors emphasize the importance of the clinical and evolving aspect of the lesions, long-term development, as well as the response to treatment (an antimalarial synthesis, applied systematically and infiltrates with betamethasone solution) in order to reach valid diagnostic conclusions. It is important in the anatomopathological study to include the atrophic zones of the central portion of the discoid lesion.


Assuntos
Lúpus Eritematoso Discoide/diagnóstico , Estomatite/etiologia , Adulto , Betametasona/uso terapêutico , Queilite/tratamento farmacológico , Queilite/etiologia , Feminino , Humanos , Lúpus Eritematoso Discoide/tratamento farmacológico , Lúpus Eritematoso Discoide/patologia , Pessoa de Meia-Idade , Estomatite/diagnóstico , Estomatite/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA